Telehealth for Osteoporosis: Lessons Learned and Opportunities for Growth

Thursday, March 30, 2023

10:45 AM – 11:45 AM

Location: Northbrook Ballroom

*Speaker(s)

E. Michael Lewiecki, MD, FACP, FACE, CCD (he/him/his)

Director
New Mexico Clinical Research & Osteoporosis Center

Disclosure(s): Amgen: Consulting Fee (e.g., Advisory Boards) (Ongoing), Contracted Research (PI’s must provide disclosure in this category) (Ongoing), Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Ongoing); Radius: Contracted Research (PI’s must provide disclosure in this category) (Ongoing)

Handouts

*Moderator(s)

TW

Thomas J. Weber, MD, CCD

Professor of Medicine
Duke University

Disclosure(s): AgNovos Healthcare (DSMB member): Other (Ongoing); HMP Global (XLH/TIO online CME lectures): Other (Ongoing); Ultragenyx: Contracted Research (PI’s must provide disclosure in this category) (Ongoing)

Disclosure(s):

E. Michael Lewiecki, MD, FACP, FACE, CCD: Amgen: Consulting Fee (e.g., Advisory Boards) (Ongoing), Contracted Research (PI’s must provide disclosure in this category) (Ongoing), Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus) (Ongoing); Radius: Contracted Research (PI’s must provide disclosure in this category) (Ongoing)

Thomas Weber, MD, CCD: AgNovos Healthcare (DSMB member): Other (Ongoing); HMP Global (XLH/TIO online CME lectures): Other (Ongoing); Ultragenyx: Contracted Research (PI’s must provide disclosure in this category) (Ongoing)

While the COVID-19 pandemic adversely affected health and clinical care overall, it also facilitated the development of alternative care models. We will review the current and potential future role of telehealth in the management of patients with osteoporosis.

Learning Objectives:

Define TeleHealth and TeleMedicine.
Describe the ECHO model of technology-enabled collaborative learning.
Demonstrate progress, challenges and opportunities for TeleHealth to improve the care of patients with skeletal diseases.